Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/16443686

Proc. Natl. Acad. Sci. U.S.A. 2006 Feb 7 103 6 1888-93

Download in:

View as

Triples

General Info

PMID
16443686